Publicacións nas que colabora con Rebeca Ortega Herrera (5)

2019

  1. Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity

    British Journal of Haematology, Vol. 187, Núm. 1, pp. 93-104

2018

  1. Mesenchymal Stromal Cell Irradiation Interferes with the Adipogenic/Osteogenic Differentiation Balance and Improves Their Hematopoietic-Supporting Ability

    Biology of Blood and Marrow Transplantation, Vol. 24, Núm. 3, pp. 443-451

2017

  1. HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: A new therapeutic target?

    Oncotarget, Vol. 8, Núm. 17, pp. 28187-28202

  2. Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis

    PLoS ONE, Vol. 12, Núm. 8

2016

  1. MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry

    Cell Communication and Signaling, Vol. 14, Núm. 1